{"version":"1.0","provider_name":"Breakthrough T1D","provider_url":"https:\/\/breakthrought1d.eu\/nl","author_name":"ylt-admin","author_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/","title":"Psoriasis medicijn kan auto-immuunreactie T1D remmen - Breakthrough T1D","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"om2u0INllw\"><a href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/\">Psoriasis medicijn kan auto-immuunreactie T1D remmen<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/embed\/#?secret=om2u0INllw\" width=\"600\" height=\"338\" title=\"&#8220;Psoriasis medicijn kan auto-immuunreactie T1D remmen&#8221; &#8212; Breakthrough T1D\" data-secret=\"om2u0INllw\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/breakthrought1d.eu\/nl\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Door Breakthrough T1D gefinancierde onderzoekers in de Verenigde Staten hebben ontdekt dat het medicijn Alefacept, wat gebruikt wordt bij de huidziekte psoriasis ervoor kan zorgen dat de insulineproducerende cellen bij Type 1 Diabetes (T1D) niet langer vernietigd worden. In een tweejarig onderzoek bij mensen die kort gediagnosticeerd waren met T1D werd vastgesteld dat mensen die [&hellip;]","thumbnail_url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-300x300-1.jpg"}